ʻO ka mālamaʻana i ka carcinoma carcinoma: kahi pathology e hōʻike ana i ka pata o ka carcinoma: heʻano maʻamau Hōʻike kēia alakaʻi i nā mea nui o nā mea ʻO ka mālamaʻana i ka mālamaʻana i nā kikowaena cancinoma pastlines, kōkua i ka hoʻomaopopoʻana i ka maʻi maʻi a me ka hoʻokele. ʻO kēiaʻikepili no nā kumu hoʻonaʻauao aʻaʻole ia he mea aʻoaʻo lapaʻau. E kūkākūkā mau me kahi mea olakino olakino no nā hopohopo olakino.
Ke hoʻomakaʻana i ka carcinoma crencinoma
Moihuauahina
Hōʻikeʻo RCC i nā subtypes tomstological, kēlā me kēia me nā hiʻohiʻona kūlike me ka hanaʻana i ka prognosis a me ka mālamaʻana. ʻO ka meaʻoi loa ka mea nui loa i ka cell cell rc ʻO nā subtypes nui'ē aʻe i loaʻa i ka papillary rcc (prcc), chromophobe rc ʻOkoʻa kēia mau subtypes i kā lākou hoʻololi genetic, nā hiʻohiʻona ulu, a me nā pane i ka mālama. ʻO ka papa hana pololei he mea nui no ke alakaʻiʻana
ʻO ka mālamaʻana i ka mālamaʻana i nā kikowaena cancinoma pastlines. ^. No kaʻike hou aku i kēia mau subtypes, e koho i nā kumuwaiwai pathology.
Ka nui a me ke kauʻana
Ua loiloi ka'ōnaehana Guhman Guding Study i ka papa inoa o RCC, e hōʻike ana i ka hanaʻana o ka tumor. ʻOi aku ka nui o nā helu kiʻekiʻe me ka prongris porer. ʻO ka hoʻopaʻaʻana, me ka hoʻohanaʻana i ka'ōnaehana tnm ʻO kahiʻike nui loa o ka nui a me ka staging he mea nui loa no ka hoʻolālā hoʻomaʻamaʻa maikaʻiʻana. E hoʻoikaika nui ka pae kūpono a me ka papa kūpono i kāu
ʻO ka mālamaʻana i ka mālamaʻana i nā kikowaena cancinoma pastlines.
Molecular pathology a me nā mea i hoʻopaʻaʻia
Loli nā geneic
Nā hui genetic kiko'ī a me nā hoʻololi hoʻololi i ka hoʻolālā rcc a me ka holomua. VHL ʻO ka hoʻomaopopoʻana i kēia mau mea hoʻokele genetic e hoʻoikaika i ke kohoʻana o nā hana i kohoʻia. Keʻike nei i kēia mauʻano gentic hiki ke kōkua i ka hana hou aku
ʻO ka mālamaʻana i ka mālamaʻana i nā kikowaena cancinoma pastlines.
Nā mea i manaʻoʻia
Ua hoʻohanaʻia nā mea hana i nā mea hana i kēia mau manawa genetic, koho i keʻano o nā ala molecular i komo i loko o ka ulu nui. Nā hiʻohiʻona e hoʻopili ai i ka tyrostine Kinane i nā Irisitens (TKIS), e like me Suntinib a me Pazopanib ʻO kēia mau mea hana pinepine i kahi'āpana o ka hoʻolālā hoʻolālā e pili ana i ka kiko'ī
ʻO ka mālamaʻana i ka mālamaʻana i nā kikowaena cancinoma pastlines ua maopopo.
Immunohiisomistlē (ihc) i rc
Pāʻaniʻo Ihc i kahi kūlana koʻikoʻi ma keʻano o ka hāpaiʻana a me ka subfyping rc. ʻO nā hōʻailona e like me CD10 a me ka vimentin ke kōkua i nā'āpana likeʻole rcc subtyps. Ua hoʻohana pūʻiaʻo IHC e loiloi i nā biogickers e wānana i ka pane e hoʻopili ai i ka mālamaʻana.
E noʻonoʻo ana i ka maʻi maʻi a me ka mālama mālamaʻana
ʻO ka noʻonoʻoʻana i nāʻenehana e like me nā scans ct a me mri scans e hāʻawi i nāʻike koʻikoʻi e pili ana i ka nui o ka tumor, wahi, a me ka metastasis. He mau mea nui kēia i ka hoʻokumuʻana i nā kiko'ī
ʻO ka mālamaʻana i ka mālamaʻana i nā kikowaena cancinoma pastlines. ^. Hoʻohanaʻia ka noʻonoʻo maʻamau i ka paneʻana i ka mālama mālamaʻana a nānā i ka recurrence.
Nā hoʻolālā lapaʻau
ʻO ke koho o ka hana e pili ana i nā kumuwaiwai, me nāʻano tumor, ka papa, a me nā hiʻohiʻona maʻi. Nā koho e kau ai i ka hana, nā mea i mālamaʻia, nā mea hana, immunotherapy, a me kaʻoihana radiation. Hoʻoholoʻia ke ala maikaʻi loa e noʻonoʻo pono i ka noʻonoʻo
ʻO ka mālamaʻana i ka mālamaʻana i nā kikowaena cancinoma pastlines.
ʻO ka hana o ka hanaʻo Shandong Banufa Cancer noiʻi noiʻi
No ka mālamaʻana i ka maʻi maʻi maʻi maʻi, me nā mea i loaʻa i nā mea lapaʻau e pono ai a me nāʻoihana mālama pilikino no ka carcina o ka carcina carcai carcai carcea. E aʻo hou e pili ana i kā lākou noiʻi holomuaʻana a me ka hoʻomauʻana i ka mea hoʻomanawanui e mālamaʻia e ka nānāʻana i kā lākou pūnaewele:
https://www.baoorHospition.com/. ^. ʻO kā lākou manaʻo ma luna o ka hoʻopiliʻana i ka noiʻiʻana i ka hana i ka hoʻomohalaʻana i ka hoʻomohalaʻana o ka hoʻomaikaʻi
ʻO ka mālamaʻana i ka mālamaʻana i nā kikowaena cancinoma pastlines.
SMMMARY papa: RCC subtypes
Subtype | Nāʻano hiʻohiʻona | Hoahewa |
Hoʻomaʻemaʻe iā RCC | Cyoplasm cytoplasm, VHL Gene Inctivation | ʻAno maʻamau, pili pinepine me ka metastasis |
Papillary RCC | ʻO Papillary Architecture, hālāwai i nā loli | Hana maʻamau |
Chromophobe rcc | Pale cytoplasssm | Hana maʻamau |
ʻO ka hoʻolahaʻana:ʻO kēiaʻikepili no nā kumu hoʻonaʻauao wale nō aʻaʻole pono e manaʻoʻia i nā'ōlelo lapaʻau. E kūkākūkā mau me kahiʻoihana olakino olakino kūpono no ka maʻi maʻi a me ka mālamaʻana i kekahi kūlana olakino.